Evaluation of intraoperative brain natriuretic peptide as a predictor of 1-year mortality after liver transplantation

Transplantation Proceedings

Volumn 43, Issue 5, 2011, Pages 1684-1690

  Kim, Y K ^a   Shin, W J ^a   Song, J G ^a   Kim, Y ^a   Kim, W J ^a   Kim, S H ^a   Hwang, G S ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN;

ADULT; ARTICLE; CENTRAL VENOUS PRESSURE; CHILD PUGH SCORING SYSTEM; CONTROLLED STUDY; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORING SYSTEM; MORTALITY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; ROC CURVE;

EID: 79959396006     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.02.010     Document Type: Article

References (39)

1. H. Jeon, and S.G. Lee Living donor liver transplantation Curr Opin Organ Transplant 15 2010 283
2. G.S. Hwang, and S.A. McCluskey Anesthesia and outcome after partial hepatectomy for adult-to-adult donor transplantation Curr Opin Organ Transplant 15 2010 377
3. Y.K. Kim, J.H. Chin, and S.J. Kang Association between central venous pressure and blood loss during hepatic resection in 984 living donors Acta Anaesthesiol Scand 53 2009 601
4. R.W. Busuttil, A. Shaked, and J.M. Millis One thousand liver transplants The lessons learned Ann Surg 219 1994 490
5. P.J. Thuluvath, H.Y. Yoo, and R.E. Thompson A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics Liver Transpl 9 2003 527
6. G.W. Dec, N. Kondo, and M.L. Farrell Cardiovascular complications following liver transplantation Clin Transplant 9 1995 463
7. J. Pruthi, K.A. Medkiff, and K.T. Esrason Analysis of causes of death in liver transplant recipients who survived more than 3 years Liver Transpl 7 2001 811
8. J.M. Rabkin, V. de La Melena, and S.L. Orloff Late mortality after orthotopic liver transplantation Am J Surg 181 2001 475
9. M.S. Mandell, J. Lindenfeld, and M.Y. Tsou Cardiac evaluation of liver transplant candidates World J Gastroenterol 14 2008 3445
10. P. Krishnaswamy, E. Lubien, and P. Clopton Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction Am J Med 111 2001 274
11. W.J. Shin, Y.K. Kim, and G.S. Hwang Serial monitoring of B-type natriuretic peptide in management of heart failure after liver transplantation in a patient with Budd-Chiari syndrome: case report Transplant Proc 42 2010 2791
12. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161
13. S. de Denus, C. Pharand, and D.R. Williamson Brain natriuretic peptide in the management of heart failure: the versatile neurohormone Chest 125 2004 652
14. R.N. Rodseth, L. Padayachee, and B.M. Biccard A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients Anaesthesia 63 2008 1226
15. B.H. Cuthbertson, G. Card, and B.L. Croal The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery Anaesthesia 62 2007 875
16. A.A. Fox, S.K. Shernan, and C.D. Collard Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting J Thorac Cardiovasc Surg 136 2008 452
17. R. Yildiz, B. Yildirim, and M. Karincaoglu Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients J Gastroenterol Hepatol 20 2005 1115
18. S. Moller, and J.H. Henriksen Cirrhotic cardiomyopathy J Hepatol 53 2010 179
19. Y.K. Kim, W.J. Shin, and J.G. Song Comparison of stroke volume variations derived from radial and femoral arterial pressure waveforms during liver transplantation Transplant Proc 41 2009 4220
20. Y.K. Kim, W.J. Shin, and J.G. Song Effect of right ventricular dysfunction on dynamic preload indices to predict a decrease in cardiac output after inferior vena cava clamping during liver transplantation Transplant Proc 42 2010 2585
21. W.D. Carey, J.A. Dumot, and R.R. Pimentel The prevalence of coronary artery disease in liver transplant candidates over age 50 Transplantation 59 1995 859
22. J.S. Plotkin, V.L. Scott, and A. Pinna Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation Liver Transpl Surg 2 1996 426
23. M. Torregrosa, S. Aguade, and L. Dos Cardiac alterations in cirrhosis: reversibility after liver transplantation J Hepatol 42 2005 68
24. A. Matsumori Hepatitis C virus infection and cardiomyopathies Circ Res 96 2005 144
25. B.G. Keeffe, H. Valantine, and E.B. Keeffe Detection and treatment of coronary artery disease in liver transplant candidates Liver Transpl 7 2001 755
26. F. Wong, N. Girgrah, and J. Graba The cardiac response to exercise in cirrhosis Gut 49 2001 268
27. R.N. Rabie, M. Cazzaniga, and F. Salerno The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt Am J Gastroenterol 104 2009 2458
28. M. Cazzaniga, F. Salerno, and G. Pagnozzi Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt Gut 56 2007 869
29. C.P. Snowden, T. Hughes, and J. Rose Pulmonary edema in patients after liver transplantation Liver Transpl 6 2000 466
30. C.L. Donovan, P.A. Marcovitz, and J.D. Punch Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation Transplantation 61 1996 1180
31. J.A. Doust, E. Pietrzak, and A. Dobson How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review BMJ 330 2005 625
32. F. Wong, S. Siu, and P. Liu Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci (Lond) 101 2001 621
33. J. Pimenta, C. Paulo, and A. Gomes B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis Liver Int 30 2010 1059
34. R.P. Myers, and S.S. Lee Cirrhotic cardiomyopathy and liver transplantation Liver Transpl 2000 S44
35. D.M. Lloyd-Jones, D.O. Martin, and M.G. Larson Accuracy of death certificates for coding coronary heart disease as the cause of death Ann Intern Med 129 1998 1020
36. J.D. Sington, and B.J. Cottrell Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings J Clin Pathol 55 2002 499
37. S. Saab, V. Wang, and A.B. Ibrahim MELD score predicts 1-year patient survival post-orthotopic liver transplantation Liver Transpl 9 2003 473
38. P.H. Hayashi, L. Forman, and T. Steinberg Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients Liver Transpl 9 2003 737
39. W.J. Hwang, J.P. Jeon, and S.H. Kang Sluggish decline in a post-transplant model for end-stage liver disease score is a predictor of mortality in living donor liver transplantation Korean J Anesthesiol 59 2010 160